Brachyury Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Brachyury monoclonal antibodies for research applications. Brachyury monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Brachyury is a T-box transcription factor that plays a pivotal role in embryonic development and the formation of the mesoderm. Research has shown that Brachyury expression influences tumor progression and metastasis in various cancers. Understanding Brachyury function is essential for elucidating developmental processes and exploring potential therapeutic targets in oncology. Ongoing research continues to reveal new insights about Brachyury's role in both normal development and disease states. Advanced detection methods enable researchers to track Brachyury expression patterns across different cellular environments. Current studies focus on understanding how Brachyury regulates gene expression networks during development and cancer progression. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of Brachyury's biological significance.